Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower Respiratory Tract Microbiome and Immunomodulators in Non-CF Bronchiectasis
ChiCTR-IPR-17011312Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of erythromycin in bronchiectasis (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Frequency of acute exacerbations, Pulmonary function and 3 more. Started May 2017; status: recruiting.
02
Drugs
erythromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ChiCTR-IPR-17011312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011312.